NephLong
Palbonix 125 Capsule
Details
100 mg
125 mg
Product Name: Palbonix
Generic Name: Palbociclib
Strengths Available: 100 mg / 125 mg
Dosage Form: Capsule / Tablet (typically oral)
Product Description:
Palbonix contains Palbociclib, a targeted anticancer agent classified as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is used primarily in combination with endocrine therapy (such as letrozole or fulvestrant) for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer in adults.
Common Dosage:
-
Typically taken once daily for 21 consecutive days, followed by a 7-day rest period, in 28-day cycles.
-
The starting dose is usually 125 mg, but may be reduced to 100 mg or lower based on patient tolerance or side effects.
Keto Nephron™ DS is a Medical Food as defined under 21 U.S.C. §360ee(b)(3) and 21 CFR 101.9(j)(8), formulated for the dietary management of Chronic Kidney Disease (CKD) Stages 3-5 in adults following physician-supervised protein-restricted diets. It is not a drug, not a dietary supplement, and is not intended for self-medication or general wellness use. MUST BE USED UNDER MEDICAL SUPERVISION. Quantum LifeSciences Inc., Claremont, CA 91711, USA. FDA Food Facility (Manufacturer) Reg. No. 14961463490.